Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (4): 400-403.DOI: 10.3969/j.issn.1673-8640.2021.04.011

Previous Articles     Next Articles

Role of blood glucose variability in the prognosis of severe corona virus disease 2019 patients

HU Senan1, TAN Junfeng2, PENG Chang2, AI Honghong2, LI Dan1   

  1. 1. Department of Clinical Laboratory,the People's Hospital of Gaoming District,Foshan 528500,Guangdong,China
    2. Department of Respiratory Medicine,the People's Hospital of Gaoming District,Foshan 528500,Guangdong,China
  • Received:2020-07-03 Online:2021-04-30 Published:2021-04-28

Abstract:

Objective To investigate the role of blood glucose variability in the prognosis of patients with severe and critical(collectively referred to as severe) corona virus disease 2019(COVID-19) patients. Methods The general data of 83 patients with severe COVID-19 were collected,and acute physiological and chronic health evaluation Ⅱ(APACHEⅡ) score when transferred to intensive care unit(ICU),dynamic glucose variability data within 72 h [mean glucose fluctuation amplitude(Glu-MAGE),glucose-coefficient of variation(Glu-CV),glucose instability index(Glu-GLI) and 72 h mean glucose] were recorded. According to the prognosis of 28 d,the patients were classified into survival group and death group. According to the patients' average 72 h blood glucose,the cut-off values of 11.1 and 7.8 mmol/L,the patients were classified into >11.1 mmol/L ,7.8-11.1 mmol/L and <7.8 mmol/L groups. Based on the results 72 h Glu-CV,the patients were classified into 4 groups by quartiles(Q1-Q4). According to the history of diabetes,the patients were classified into non-diabetic group and diabetic group. Blood glucose variability and mortality were compared in each group. Results The age,APACHEⅡ score,72 h mean glucose,Glu-MAGE,Glu-GLI,Glu-CV of death group were higher than those of survival group(P<0.05). In the >11.1 mmol/L group,Glu-MAGE,Glu-CV were higher than those in 7.8-11.1 mmol/L and <7.8 mmol/L groups(P<0.05). There was no statistical significance between 7.8-11.1 mmol/L group and <7.8 mmol/L group(P>0.05). The other items were not statistically significant among the 3 groups(P>0.05). The 28 d mortality increased with the increase of blood glucose,and the difference among the 3 groups had statistical significance(P<0.05). In Q1-Q4 groups,the 28 d mortality rate of 28 d of diabetic patients was higher than that of non-diabetic patients(P<0.05). With or without diabetes,the 28 d mortality rate increased with the increase of Glu-CVP<0.05). Conclusions Death risk in patients with severe COVID-19 increases with the increasing of blood glucose variability.

Key words: Glucose variability, Corona virus disease 2019, Prognosis

CLC Number: